CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 600 | -72.2% | 0.00% | – |
| Q3 2017 | $4,000 | +33.3% | 2,162 | +260.3% | 0.00% | – |
| Q2 2017 | $3,000 | +200.0% | 600 | +40.2% | 0.00% | – |
| Q1 2017 | $1,000 | -87.5% | 428 | -85.6% | 0.00% | – |
| Q4 2016 | $8,000 | -63.6% | 2,980 | +10.0% | 0.00% | – |
| Q4 2015 | $22,000 | +214.3% | 2,709 | +214.6% | 0.00% | – |
| Q3 2015 | $7,000 | -90.5% | 861 | -89.0% | 0.00% | – |
| Q2 2015 | $74,000 | +89.7% | 7,849 | +85.0% | 0.00% | – |
| Q1 2015 | $39,000 | +2.6% | 4,243 | +3.2% | 0.00% | – |
| Q4 2014 | $38,000 | – | 4,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,241,550 | $7,520,000 | 4.03% |
| Tamarack Advisers, LP | 1,875,000 | $4,350,000 | 2.07% |
| CLOUGH CAPITAL PARTNERS L P | 2,075,663 | $4,816,000 | 0.46% |
| Rock Springs Capital Management LP | 1,200,000 | $2,784,000 | 0.12% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,192,034 | $9,726,000 | 0.08% |
| PUTNAM INVESTMENTS LLC | 3,092,133 | $7,174,000 | 0.02% |
| Renaissance Technologies | 528,913 | $1,227,000 | 0.00% |
| SCOTIA CAPITAL INC. | 19,120 | $44,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 51,200 | $118,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 700 | $2,000 | 0.00% |